Table 2.
Univariate and multivariate logistic regression analyses for total prostate cancer risk.
| Univariate logistic regression | Multivariate logistic regression | |||||||
|---|---|---|---|---|---|---|---|---|
| OR | 95% CI | p | OR | 95% CI | p | |||
| Lower | Upper | Lower | Upper | |||||
| Age, yr | ||||||||
| ≤65 | <0.0001 | 0.001 | ||||||
| 66–70 | 2.510 | 1.585 | 3.974 | <0.0001 | 2.850 | 1.633 | 4.973 | <0.0001 |
| 71–75 | 2.157 | 1.400 | 3.322 | <0.0001 | 1.642 | 0.959 | 2.810 | 0.070 |
| >75 | 2.822 | 1.798 | 4.429 | <0.0001 | 2.340 | 1.307 | 4.191 | 0.004 |
| PSA, ng/mL | ||||||||
| ≤6 | <0.0001 | |||||||
| 6.1–8 | 1.781 | 1.101 | 2.881 | 0.019 | ||||
| 8.1–10 | 1.920 | 1.143 | 3.225 | 0.014 | ||||
| >10 | 3.701 | 2.454 | 5.582 | <0.0001 | ||||
| PSA density, ng/mL/mL | ||||||||
| ≤0.15 | <0.0001 | <0.0001 | ||||||
| 0.151–0.29 | 3.012 | 1.989 | 4.561 | <0.0001 | 2.350 | 1.501 | 3.680 | <0.0001 |
| 0.3–0.44 | 5.857 | 2.852 | 12.028 | <0.0001 | 3.887 | 1.797 | 8.406 | 0.001 |
| >0.45 | 16.343 | 8.081 | 33.049 | <0.0001 | 9.445 | 4.341 | 20.547 | <0.0001 |
| TRUS prostate volume, mL | ||||||||
| <20 | <0.0001 | |||||||
| 21–30 | 1.118 | 0.456 | 2.743 | 0.808 | ||||
| 31–40 | 1.184 | 0.503 | 2.787 | 0.698 | ||||
| >40 | 0.342 | 0.155 | 0.753 | 0.008 | ||||
| mpMRI prostate volume, mL | ||||||||
| <20 | <0.0001 | |||||||
| 21–30 | 1.207 | 0.423 | 3.443 | 0.726 | ||||
| 31–40 | 0.528 | 0.199 | 1.404 | 0.201 | ||||
| >40 | 0.288 | 0.114 | 0.727 | 0.008 | ||||
| DRE | ||||||||
| Positive | 3.031 | 2.150 | 4.274 | <0.0001 | 1.357 | 0.880 | 2.093 | 0.167 |
| PI-RADS score | ||||||||
| PI-RADS 2 | <0.0001 | <0.0001 | ||||||
| PI-RADS 3 | 1.333 | 0.707 | 2.516 | 0.374 | 1.242 | 0.613 | 2.516 | 0.547 |
| PI-RADS 4 | 2.534 | 1.413 | 4.544 | 0.002 | 2.077 | 1.090 | 3.957 | 0.026 |
| PI-RADS 5 | 10.264 | 5.391 | 19.540 | <0.0001 | 4.847 | 2.357 | 9.970 | <0.0001 |
CI = confidence interval; DRE = digital rectal examination; mpMRI = multiparametric magnetic resonance imaging; OR = odds ratio; PI-RADS = Prostate Imaging Reporting and Data System; PSA = prostate-specific antigen; TRUS = transrectal ultrasound.